Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Integromics and Ingenuity Expand their Co-operation with the Integration of a Fourth Integromics Product to Ingenuity’s IPA

Published: Thursday, April 07, 2011
Last Updated: Thursday, April 07, 2011
Bookmark and Share
Combined solutions to offer bridge between discovery and relevance of genomics and proteomics.

Integromics, has announced that it has extended its partnership with Ingenuity®, a provider of information and analytics solutions for life science researchers. The partnership extension involves the scheduled integration of Integromics’ fourth product, SeqSolve™ to offer the most complete collection of Omics tools integrated with Ingenuity’s IPA® software.

The SeqSolve analysis software, exclusively designed for Next Generation Sequencing (NGS), performs tertiary level analysis of RNA-seq data at the gene and transcript level for biologically relevant results. Integromics has already integrated three solutions with Ingenuity’s IPA: Integromics Biomarker Discovery® for microarray data analysis, RealTime StatMiner® for the analysis of qPCR data as well as OmicsHub® Proteomics for the analysis and storage of proteomics data.

Ingenuity’s technology differs from competitors in the automation API that allows integration with third-party tools, like Integromics’ SeqSolve. The combined solutions will enable users to go from the aligned sequences to the function, interactions, pathways and disease association of the genes or variant forms identified in the experiment.

Ingenuity gains access to the NGS and proteomics domains as well as a powerful suite of genomics tools and a proteomics tool tightly integrated with their pathway tool.

There has been increasing and significant demand for NGS technology in recent years. However, high-impact biological interpretation of NGS data sets has been limited. Currently, the vast majority of the existing tools for analyzing NGS data only reach secondary analysis with a complex user experience.

This is centered on the alignment of the sequence from the instrument against a reference without genome-wide profiling of biologically significant genomics features, nor advanced statistical support for differential gene expression.

“The integration of Integromics’ four products to Ingenuity’s IPA product provides greater information between the discovery of differentially expressed genes, novel or differential splice forms, proteins, and the clinical or medical relevance of the findings,” said Dr. Michael J. McManus, CEO, Integromics. “Integromics can offer the market a spectrum of coverage spanning from microarrays to NGS data and proteomics while providing a consistent interface to IPA’s pathway data and biological context in each of the Integromics products.”

“We are very pleased to work with Integromics to integrate IPA with SeqSolve,” said Doug Bassett, Ph.D., CSO and CTO, Ingenuity Systems. “Researchers with RNA-seq data will have a trusted and streamlined workflow to help them narrow in on what is most important in their data set and get to powerful biological insights.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Integromics Partners with CITRE and CEIT
Venture attracts EUR 2 million grant for ‘new frontier’ of data interpretation for drug development.
Friday, April 19, 2013
Integromics Invests in the Optimization of Computing Performance for Bioinformatics Applications
Key collaboration with European experts of HPC to bring new big-data computing solutions into genomics.
Friday, March 22, 2013
Integromics Partners with FPGMX to Develop Low-Cost Methods for Clinical Genomics
Venture attracts EUR one million grant for ‘new frontier’ of data interpretation for medical usage.
Tuesday, February 07, 2012
Novel Polyadenylation Genome-wide Profiling Achieved using Next Generation Sequencing Software
A paper published in the journal Cell highlighting a novel genome wide profile of polyadenylation events in human and yeast, performed with Direct RNA Sequencing, demonstrated the importance of appropriate bioinformatics software in maximizing the value of the genomic data.
Monday, January 10, 2011
Integromics and TATAA Biocenter Collaborate to offer Comprehensive qPCR Data Analysis
The TATAA Biocenter is recommending Integromics’ RealTime StatMiner® as a complete solution for qPCR data analysis.
Monday, March 08, 2010
Integromics S.L. Integrates GeneBio’s Phenyx within OmicsHub Proteomics
Geneva Bioinformatics (GeneBio) SA and Integromics S.L. today announced that GeneBio's Phenyx software platform for MS data analysis has been successfully integrated into Integromics’ latest proteomics data analysis and management tool - OmicsHub Proteomics. This integration gives Phenyx and OmicsHub Proteomics users the possibility of combining results from different search engines thereby increasing the accuracy of the protein identification process.
Wednesday, September 23, 2009
Scientific News
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Key to Natural Detoxifier’s Reactivity Discovered
Results have implications for health, drug design and chemical synthesis.
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
Will Brain Palpation Soon Be Possible?
Researchers have developed non-invasive brain imaging technique which provides the same information as physical palpation.
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Michigan Researchers Use Raman Spectroscopy
inVia confocal Raman microscope used in the study of various childhood diseases.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos